Thursday, Apr 25, 2024
Focus on the big picture

Eli Lilly says its drug cuts COVID risk in nursing homes

Reuters, 22 Jan 2021
Drugmaker Eli Lilly said a trial of its antibody drug, bamlanivimab, showed it can reduce the risk of COVID-19 by 80% for nursing home residents.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
#COVID-19 #News
Related Articles